Share Your Perspective: EAHAD Survey on Gene Therapy in Haemophilia Care
European Association for Haemophilia and Allied Disorders (EAHAD) shared an inviting post on LinkedIn:
“Gene therapy brings exciting possibilities for people with haemophilia, but effective care depends on how well healthcare professionals understand, discuss, and integrate it into practice.
We’re conducting a Europe-wide survey to explore current understanding, clinical experience, and decision-making around gene therapy among physicians, nurses, physiotherapists, psychologists, and all professionals involved in haemophilia care.
Your input will help identify educational needs, support better patient communication, and strengthen shared decision-making in clinical practice.”
Your perspective matters, take the survey here.
Stay updated on the emerging with Hemostasis Today.
-
May 27, 2026, 04:47Daniel Torrent: The Overlooked Epidemic of Post-Thrombotic Syndrome
-
May 27, 2026, 04:45Graziella Pompei: Is Aspirin Still a Valid Alternative to Clopidogrel in PCI with DES Implantation?
-
May 27, 2026, 04:40Kausik Ray: Phase 1 Trial Highlights Anti-Inflammatory Effects of Ruvonoflast
-
May 27, 2026, 04:29Francisco Chacón-Lozsán: High-Sensitivity Troponin and the Evolving Management of NSTEMI
-
May 27, 2026, 04:14Michael R. Jaff: HI-PEITHO Trial and NEWS Score Insights on Advances for Intermediate-Risk Pulmonary Embolism
-
May 26, 2026, 16:45Ashley George: Take the Leap for Thrombosis UK
-
May 26, 2026, 16:40Hamed Helisaz: Machine Learning for Detecting Missing Heart Medications
-
May 26, 2026, 15:32Haroun Gajraj: Brown Marks After Microsclerotherapy – What Every Practitioner Needs to Know
-
May 26, 2026, 15:29Jacqueline van Paassen: Lack of Essential Clinical Data in DOAC Prescriptions in Community Pharmacies